Search results
Added:
2 years ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU.
This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282…
View more
Added:
2 weeks ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more
The Hybrid Approach in CAD with Restore® DEB
Video Series
Added:
1 year ago
With focus on the 2024 ESC chronic coronary syndromes (CCS) guidelines – that highlighted significant advancements in the recommendations for fractional flow reserve computed tomography (FFRCT) and coronary computed tomography angiography (CTA) – this insightful series aims to equip healthcare professionals with the latest clinical strategies and practical tools for integrating FFRCT and coronary…
View more
Added:
2 months ago
Added:
2 years ago
This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD).He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation.To…
View more
Added:
1 year ago
EuroPCR 24 - We are joined onsite by Dr Carlos Collet (OLV Hospital Aalst, BE) to discuss the findings from a study analysing the influences of the pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI.The study aimed to assess the capacity of pullback pressure gradient (PPG) in predicting post-PCI fractional flow ratio (FFR), as well as the impact of PPG on…
View more
Management of CAD in TAVI
Added:
4 months ago
Article
Added:
1 year ago
Added:
7 months ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical…
View more